id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-1179-0003,FDA,FDA-2015-E-1179,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-03T05:00:00Z,2015,11,2015-11-03T05:00:00Z,,2015-11-03T15:04:35Z,,0,0,0900006481d0793a
FDA-2015-E-1179-0002,FDA,FDA-2015-E-1179,Patent Extension Application from Buchanan Ingersoll & Rooney (on behalf of Bayer Intellectual Property GmbH),Other,Application,2015-04-09T04:00:00Z,2015,4,2015-04-09T04:00:00Z,,2015-04-09T21:23:46Z,,0,0,0900006481a9c654
FDA-2015-E-1179-0001,FDA,FDA-2015-E-1179,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-04-09T04:00:00Z,2015,4,2015-04-09T04:00:00Z,,2015-04-09T21:22:57Z,,0,0,0900006481a9c655